Sven Beyes was born in Ludwigsburg, Germany, in 1987. He studied Technical Biology (Diploma) at the University of Stuttgart, with stays at the University Hospital of Würzburg, the Universitat Autònoma de Barcelona, Spain and at the Eötvös Lorànd University in Budapest, Hungary. For his PhD he joined 2014 the group of Andreas Hecht at the Institute of Molecular Medicine and Cell Research in Freiburg. His research focus was on SNAIL1-mediated transcriptional control of epithelial-mesenchymal transition. After obtaining his PhD in 2019, he moved to CIBIO at the University of Trento, Italy, to join the group of Alessio Zippo and focus on enhancer reprogramming during breast cancer progression. In 2020, Sven received a Walter-Benjamin-Fellowship of the German Research Foundation (DFG) to study tumor-dependent changes in mitotic bookmarking of triple-negative breast cancer cells. In 2023, he returned to Germany with a Return Fellowship of the DFG. In October 2024, he started as a junior research group leader at the RBCT to investigate cancer therapy-induced alterations of mitotic bookmarking and their contribution to therapy resistance development.
